Mesoblast Limited (MESO) vs Vir Biotechnology, Inc. (VIR)
- Mesoblast Limited MESO 13.28 −4.80%
- Vir Biotechnology, Inc. VIR 9.96 −4.87%
Mesoblast Limited and Vir Biotechnology, Inc. are both Biotechnology companies. Mesoblast Limited and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against −26.5%. Vir Biotechnology, Inc. has the higher net margin (−83.0% vs −1,091.7%) and the lower return on invested capital (−39.1% vs 0.00%). Across the 18 metrics below, Mesoblast Limited leads on 9 and Vir Biotechnology, Inc. on 9.
Valuation
Profitability
| Metric | MESO | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | 100.00% | 65.16% |
| Operating margin | (826.28%) | (92.40%) | 0.00% |
| Net margin | (1,091.71%) | (83.00%) | 0.00% |
| Free cash flow margin | 0.00% | (67.17%) | 0.00% |
| Return on equity | 0.00% | (26.08%) | (56.36%) |
| Return on assets | 0.00% | (20.91%) | (48.04%) |
| Return on invested capital | 0.00% | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack